We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+16.69%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$176M
AUM Growth
+$30.3M
Cap. Flow
+$13.4M
Cap. Flow %
7.61%
Top 10 Hldgs %
46.67%
Holding
67
New
5
Increased
34
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$3.07M
2
VNDA icon
Vanda Pharmaceuticals
VNDA
+$2.72M
3
ATRC icon
AtriCure
ATRC
+$2.39M
4
ANGO icon
AngioDynamics
ANGO
+$2.11M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$2.11M

Top Sells

Rank Stock Value
1
TLGT
Teligent, Inc
TLGT
+$4.59M
2
SNY icon
Sanofi
SNY
+$2.13M
3
ABCO
Advisory Board Co
ABCO
+$1.69M
4
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$1.4M
5
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
+$806K

Sector Composition

Rank Sector Weight
1 Healthcare 89.57%
2 Consumer Staples 0.89%
3 Financials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAR
26
DELISTED
TearLab Corporation
TEAR
$2.53M 1.43%
95,321
+5,675
+6% +$156K
HSTM icon
27
HealthStream
HSTM
$819M
$2.43M 1.38%
82,445
+6,431
+8% +$183K
CPHD
28
DELISTED
Cepheid Inc
CPHD
$2.42M 1.37%
44,758
+3,486
+8% +$176K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$121B
$2.09M 1.18%
17,591
+1,306
+8% +$147K
ALGN icon
30
Align Technology
ALGN
$12.1B
$2.05M 1.16%
36,739
+2,805
+8% +$148K
LMAT icon
31
LeMaitre Vascular
LMAT
$2.32B
$2.01M 1.14%
263,146
+20,178
+8% +$144K
SLXP
32
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$2M 1.13%
+17,421
New +$2.11M
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.99M 1.13%
22,062
+1,737
+9% +$144K
LCI
34
DELISTED
Lannett Company, Inc.
LCI
$1.96M 1.11%
11,441
+777
+7% +$144K
IONS icon
35
Ionis Pharmaceuticals
IONS
$8.6B
$1.82M 1.03%
29,505
+2,215
+8% +$109K
STKL
36
DELISTED
SunOpta
STKL
$1.58M 0.89%
132,984
+10,408
+8% +$130K
BLUE
37
DELISTED
bluebird bio
BLUE
$1.47M 0.83%
+1,236
New +$826K
CYTK icon
38
Cytokinetics
CYTK
$10.5B
$1.44M 0.81%
179,189
+14,143
+9% +$60.7K
SPPI
39
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1.3M 0.74%
188,172
-190,365
-50% -$1.4M
SGNT
40
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.08M 0.61%
43,081
-27,461
-39% -$806K
PETX
41
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.03M 0.59%
58,065
+4,398
+8% +$54.8K
ENDP
42
DELISTED
Endo International plc
ENDP
$589K 0.33%
8,161
– –
NVS icon
43
Novartis
NVS
$297B
$562K 0.32%
6,774
– –
VTRS icon
44
Viatris
VTRS
$20.4B
$551K 0.31%
9,775
– –
AGN
45
DELISTED
Allergan plc
AGN
$524K 0.3%
2,035
– –
ELV icon
46
Elevance Health
ELV
$81.5B
$515K 0.29%
4,095
– –
HUM icon
47
Humana
HUM
$43.7B
$508K 0.29%
3,540
– –
UTHR icon
48
United Therapeutics
UTHR
$25.8B
$495K 0.28%
3,820
– –
BMY icon
49
Bristol-Myers Squibb
BMY
$133B
$489K 0.28%
8,290
– –
CELG
50
DELISTED
Celgene Corp
CELG
$479K 0.27%
4,280
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, First Light Asset Management held 67 positions worth $176M, up 21% from $146M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

First Light Asset Management deployed $13.4M of net new capital in Q4 2014, opening 5 new positions and adding to 34 existing holdings. Its largest new stake was Veracyte: 393,926 shares worth $3.81M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Teligent, Inc, an estimated $4.59M trimmed.

  • First Light Asset Management's largest Q4 2014 buy was Veracyte: 393,926 shares worth $3.81M.
  • First Light Asset Management added most to AtriCure in Q4 2014, an estimated $2.39M increase.
  • First Light Asset Management's biggest Q4 2014 reduction was Teligent, Inc, cutting an estimated $4.59M.
  • First Light Asset Management fully exited Advisory Board Co in Q4 2014, selling an estimated $1.69M.
  • First Light Asset Management's ten largest holdings make up 47% of its $176M portfolio in Q4 2014.
  • First Light Asset Management opened 5 new positions and closed 1 in Q4 2014.
  • First Light Asset Management's portfolio value rose 21% quarter-over-quarter to $176M.

Based on First Light Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.